Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Blood VEGF level-lowering agent containing IL-6 antagonist as the active ingredient

Blood VEGF level-lowering agent containing IL-6 antagonist as the active ingredient

US Patent 8173126 · Granted May 8, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for promoting muscle regeneration by administering an antibody to the IL-2016
Therapeutic agent for chronic arthritides diseases of childhood-related diseases2016
Therapeutic agent for chronic arthritides diseases of childhood-related diseases2016
Laminated body, circuit board including laminated body, semiconductor package an2014
Mesothelioma therapeutic agent2014
Method for manufacturing laminated board, and laminated board2014
Treatment of vasculitis with IL-6 antagonist2013
Method for treating psoriasis by administering an antibody to interleukin-6 rece2013
Method for treating psoriasis by administering an antibody to interleukin-6 rece2013
Method of treating psoriatic arthritis with an IL-6 receptor antibody2013
Method of treating psoriatic arthritis with an IL-6 receptor antibody2013
Method for production of quinolone-containing lyophilized preparation2012